What is Align Technology ROE % Adjusted to Book Value?
Align Technology's ROE % for the quarter that ended in Dec. 2024 was 10.65%. Align Technology's PB Ratio for the quarter that ended in Dec. 2024 was 4.00.
Align Technology's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 2.66%.
Align Technology ROE % Adjusted to Book Value Historical Data
The historical data trend for Align Technology's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Align Technology ROE % Adjusted to Book Value Chart
Competitive Comparison of Align Technology's ROE % Adjusted to Book Value
For the Medical Instruments & Supplies subindustry, Align Technology's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Align Technology's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Align Technology's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Align Technology's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Align Technology ROE % Adjusted to Book Value Related Terms
Thank you for viewing the detailed overview of Align Technology's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ALGN has been successfully added to your 